PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2950.0
(-2.64%)
IDR 2950.0
(-2.64%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1211.28 Billion IDR | 73.91% |
| 2022 | 696.49 Billion IDR | 3.32% |
| 2021 | 674.11 Billion IDR | 480.32% |
| 2020 | 116.16 Billion IDR | 134.88% |
| 2019 | -332.99 Billion IDR | -2157.83% |
| 2018 | 16.18 Billion IDR | -82.71% |
| 2017 | 93.56 Billion IDR | 8.92% |
| 2016 | 85.9 Billion IDR | 22.02% |
| 2015 | 70.39 Billion IDR | 12.51% |
| 2014 | 62.56 Billion IDR | 25.46% |
| 2013 | 49.87 Billion IDR | -1.17% |
| 2012 | 50.46 Billion IDR | 15.37% |
| 2011 | 43.74 Billion IDR | -35.18% |
| 2010 | 67.47 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 320.6 Billion IDR | 6.65% |
| 2024 Q2 | 300.6 Billion IDR | 2097.7% |
| 2024 Q1 | 13.67 Billion IDR | -96.12% |
| 2023 Q3 | 355.53 Billion IDR | 40.11% |
| 2023 Q2 | 253.75 Billion IDR | 1.66% |
| 2023 Q1 | 249.61 Billion IDR | 0.95% |
| 2023 FY | 1211.28 Billion IDR | 73.91% |
| 2023 Q4 | 352.37 Billion IDR | -0.89% |
| 2022 FY | 696.49 Billion IDR | 3.32% |
| 2022 Q4 | 247.27 Billion IDR | 3.5% |
| 2022 Q3 | 238.91 Billion IDR | 115.21% |
| 2022 Q2 | 111.01 Billion IDR | 11.81% |
| 2022 Q1 | 99.28 Billion IDR | -30.16% |
| 2021 Q4 | 142.16 Billion IDR | -40.87% |
| 2021 Q2 | 147.64 Billion IDR | 2.6% |
| 2021 Q3 | 240.41 Billion IDR | 62.84% |
| 2021 FY | 674.11 Billion IDR | 480.32% |
| 2021 Q1 | 143.89 Billion IDR | -12.77% |
| 2020 FY | 116.16 Billion IDR | 134.88% |
| 2020 Q2 | -146.23 Billion IDR | -1002.98% |
| 2020 Q1 | 16.19 Billion IDR | 104.24% |
| 2020 Q4 | 164.95 Billion IDR | 103.03% |
| 2020 Q3 | 81.24 Billion IDR | 155.56% |
| 2019 FY | -332.99 Billion IDR | -2157.83% |
| 2019 Q3 | 37.98 Billion IDR | 2327.22% |
| 2019 Q2 | 1.56 Billion IDR | -52.99% |
| 2019 Q4 | -381.65 Billion IDR | -1104.72% |
| 2019 Q1 | 3.32 Billion IDR | -74.76% |
| 2018 Q3 | 28.04 Billion IDR | 209.78% |
| 2018 Q4 | 13.19 Billion IDR | -52.97% |
| 2018 FY | 16.18 Billion IDR | -82.71% |
| 2018 Q1 | 493 Million IDR | -98.39% |
| 2018 Q2 | -25.54 Billion IDR | -5282.35% |
| 2017 FY | 93.56 Billion IDR | 8.92% |
| 2017 Q3 | 36.02 Billion IDR | 365.78% |
| 2017 Q1 | 40.41 Billion IDR | 8863.42% |
| 2017 Q4 | 30.68 Billion IDR | -14.82% |
| 2017 Q2 | -13.55 Billion IDR | -133.54% |
| 2016 Q3 | 16.07 Billion IDR | -44.3% |
| 2016 FY | 85.9 Billion IDR | 22.02% |
| 2016 Q2 | 28.85 Billion IDR | -28.77% |
| 2016 Q1 | 40.51 Billion IDR | 3464112.56% |
| 2016 Q4 | 450.87 Million IDR | -97.2% |
| 2015 Q1 | 34.52 Billion IDR | 318.09% |
| 2015 Q2 | 27.52 Billion IDR | -20.3% |
| 2015 FY | 70.39 Billion IDR | 12.51% |
| 2015 Q4 | -1.16 Million IDR | -100.01% |
| 2015 Q3 | 8.34 Billion IDR | -69.67% |
| 2014 Q3 | 8.17 Billion IDR | -57.56% |
| 2014 Q2 | 19.25 Billion IDR | -28.36% |
| 2014 Q1 | 26.88 Billion IDR | -9.58% |
| 2014 FY | 62.56 Billion IDR | 25.46% |
| 2014 Q4 | 8.25 Billion IDR | 1.05% |
| 2013 Q4 | 29.73 Billion IDR | 1719.27% |
| 2013 Q1 | 27.16 Billion IDR | 509.43% |
| 2013 FY | 49.87 Billion IDR | -1.17% |
| 2013 Q2 | -5.18 Billion IDR | -119.1% |
| 2013 Q3 | -1.83 Billion IDR | 64.6% |
| 2012 Q4 | 4.45 Billion IDR | 0.0% |
| 2012 FY | 50.46 Billion IDR | 15.37% |
| 2011 FY | 43.74 Billion IDR | -35.18% |
| 2010 FY | 67.47 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 7.46 Billion IDR | -16134.569% |
| PT Metro Healthcare Indonesia Tbk | -110.91 Billion IDR | 1192.035% |
| PT Medikaloka Hermina Tbk | 437.34 Billion IDR | -176.962% |
| PT Mitra Keluarga Karyasehat Tbk | 916.13 Billion IDR | -32.217% |
| PT Murni Sadar Tbk | -12.83 Billion IDR | 9539.71% |
| PT Famon Awal Bros Sedaya Tbk | 216.97 Billion IDR | -458.262% |
| PT Royal Prima Tbk | -2.74 Billion IDR | 44202.758% |
| PT Kedoya Adyaraya Tbk | 25.18 Billion IDR | -4708.809% |
| PT Sarana Meditama Metropolitan Tbk | 12.25 Billion IDR | -9786.254% |
| PT Sejahteraraya Anugrahjaya Tbk | -38.49 Billion IDR | 3247.007% |